{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:49:55Z","timestamp":1786988995940,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.euo.2025.05.012","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:55:12Z","timestamp":1749196512000},"page":"1416-1427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Quality Indicators for Renal Cancer Care: A Systematic Review"],"prefix":"10.1016","volume":"8","author":[{"given":"Alessio","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Costagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kutikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant D.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Zondervan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Masieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Serni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.05.012_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2025.05.012_b0010","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1988.03410120089033","article-title":"The quality of care. How can it be assessed?","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.05.012_b0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.euf.2022.12.004","article-title":"Quality indicators in the clinical specialty of urology: a systematic review","volume":"9","author":"Koh","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.05.012_b0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bju.16530","article-title":"A decade long insight into patient views on kidney cancer care delivery","volume":"135","author":"Rossi","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.05.012_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/intqhc\/mzaa023","article-title":"Understanding unwarranted variation in clinical practice: a focus on network effects, reflective medicine and learning health systems","volume":"32","author":"Atsma","year":"2020","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.euo.2025.05.012_b0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2021.01.021","article-title":"Collaborative review: factors influencing treatment decisions for patients with a localized solid renal mass","volume":"80","author":"Chandrasekar","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2022.11.014","article-title":"A systematic review of heterogeneity in outcome definition and reporting in localised renal cancer","volume":"48","author":"Beyer","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2025.05.012_b0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0045","doi-asserted-by":"crossref","unstructured":"Bex A, Ghanem YA, Albiges L, et al. European Association of Urology guidelines on renal cell carcinoma: the 2025 update. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.020.","DOI":"10.1016\/j.eururo.2025.02.020"},{"key":"10.1016\/j.euo.2025.05.012_b0050","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/bco2.266","article-title":"A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS)","volume":"4","author":"MacLennan","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.euo.2025.05.012_b0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0060","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2025.05.012_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.euo.2025.05.012_b0070","unstructured":"J de Koning. GMS | Kongress Medizin und Gesellschaft 2007 | Development and validation of a measurement instrument for appraising indicator quality: appraisal of indicators through research and evaluation (AIRE) instrument. D\u00fcsseldorf, Germany: German Medical Science GMS Publishing House; 2007."},{"key":"10.1016\/j.euo.2025.05.012_b0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1464-410X.2010.09871.x","article-title":"Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance","volume":"108","author":"Shuch","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.05.012_b0080","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1200\/JOP.2012.000870","article-title":"Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma","volume":"9","author":"Wood","year":"2013","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.euo.2025.05.012_b0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/21681805.2015.1059882","article-title":"Impact of quality indicators on adherence to national and European guidelines for renal cell carcinoma","volume":"50","author":"Thorstenson","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5489\/cuaj.4397","article-title":"Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective","volume":"11","author":"Lawson","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euo.2025.05.012_b0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bju.14055","article-title":"Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database","volume":"121","author":"Fero","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.05.012_b0100","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/EDE.0000000000001015","article-title":"Causal mediation analysis for standardized mortality ratios","volume":"30","author":"Daignault","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.euo.2025.05.012_b0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12094-021-02703-9","article-title":"Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain","volume":"24","author":"Guillem Porta","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.euo.2025.05.012_b0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/UPJ.0000000000000294","article-title":"A novel metric for hospital quality in kidney cancer surgery: a Veterans Affairs National Health System validation of concept","volume":"9","author":"Aguilar Palacios","year":"2022","journal-title":"Urol Pract"},{"key":"10.1016\/j.euo.2025.05.012_b0115","doi-asserted-by":"crossref","first-page":"257.e7","DOI":"10.1016\/j.urolonc.2023.02.007","article-title":"Surgeon-level versus hospital-level quality variance in kidney cancer surgery","volume":"41","author":"McAlpine","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.05.012_b0120","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzad113","article-title":"The global, regional, and national burden and quality of care index of kidney cancer; a global burden of disease systematic analysis 1990\u20132019","volume":"36","author":"Khadembashiri","year":"2024","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.euo.2025.05.012_b0125","doi-asserted-by":"crossref","first-page":"e429","DOI":"10.1016\/j.clon.2024.08.008","article-title":"Variability in kidney cancer treatment and survival in England: results of a national cohort study","volume":"36","author":"Fife","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.euo.2025.05.012_b0130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000517893","article-title":"Guideline-based quality indicators for kidney and bladder cancer in Germany: development and implementation","volume":"106","author":"R\u00fcckher","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2025.05.012_b0135","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2025.05.012_b0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part II","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0145","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MLR.0b013e3181c15a6e","article-title":"Meaningful variation in performance: what does variation in quality tell us about improving quality?","volume":"48","author":"Selby","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.euo.2025.05.012_b0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.6228","article-title":"Remote monitoring and data collection for decentralized clinical trials","volume":"7","author":"Daly","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.05.012_b0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41585-024-00925-4","article-title":"PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research","volume":"22","author":"Lawlor","year":"2025","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0165","unstructured":"Public Health Scotland. Renal cancer quality performance indicators. Patients diagnosed between January 2018 and December 2020. https:\/\/publichealthscotland.scot\/publications\/renal-cancer-quality-performance-indicators\/renal-cancer-quality-performance-indicators-patients-diagnosed-between-january-2018-and-december-2020\/."},{"key":"10.1016\/j.euo.2025.05.012_b0170","unstructured":"data.gov.uk. National Kidney Cancer Audit state of the nation report 2024. https:\/\/www.data.gov.uk\/dataset\/e29d5fad-5305-4939-92c5-0f24e8239c87\/national-kidney-cancer-audit-state-of-the-nation-report-2024#."},{"key":"10.1016\/j.euo.2025.05.012_b0175","doi-asserted-by":"crossref","first-page":"71.e9","DOI":"10.1016\/j.urolonc.2024.01.011","article-title":"Urologist-level variation in the management of T1a renal cell carcinoma: a population-based cohort study","volume":"42","author":"Cheaib","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.05.012_b0180","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.juro.2012.01.076","article-title":"Volume-outcome relationships in the treatment of renal tumors","volume":"187","author":"Abouassaly","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.05.012_b0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bju.14848","article-title":"Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma","volume":"125","author":"Hsu","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.05.012_b0190","doi-asserted-by":"crossref","unstructured":"Marconi L, Kuusk T, Hora M, et al. Hospital volume as a determinant of outcomes after partial nephrectomy: a systematic review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2025.01.013.","DOI":"10.1016\/j.euo.2025.01.013"},{"key":"10.1016\/j.euo.2025.05.012_b0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejca.2023.03.028","article-title":"European Society of Breast Cancer Specialists\/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care","volume":"187","author":"Cardoso","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2025.05.012_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-022-07467-8","article-title":"The contribution of benchmarking to quality improvement in healthcare. A systematic literature review","volume":"22","author":"Willmington","year":"2022","journal-title":"BMC Health Serv Res"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:34:54Z","timestamp":1766511294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2588931125001506"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.05.012","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality Indicators for Renal Cancer Care: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}